ENW.V - EnWave Corporation

TSXV - TSXV Delayed Price. Currency in CAD
1.6000
-0.0300 (-1.84%)
At close: 3:58PM EST
Stock chart is not supported by your current browser
Previous Close1.6300
Open1.6500
Bid1.5800 x 0
Ask1.6100 x 0
Day's Range1.6000 - 1.6500
52 Week Range1.3800 - 2.6600
Volume92,118
Avg. Volume100,756
Market Cap177.339M
Beta (5Y Monthly)0.48
PE Ratio (TTM)N/A
EPS (TTM)-0.0190
Earnings DateFeb. 25, 2020 - Mar. 01, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est2.48
  • GlobeNewswire

    EnWave Signs Commercial License Agreement with Pacifico Snacks in Colombia and Receives Purchase Order for REV™ Machine

    EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”) announced today that it has signed a royalty-bearing commercial license agreement (the “License”) with Pacifico Snacks S.A.S. (“Pacifico Snacks”) to produce REV™ dried fruit snacks for the North American grocery market. Under the terms of the License, Pacifico Snacks purchased a 10kW commercial Radiant Energy Vacuum (“REV™”) machine to initiate commercial production in Colombia. The License grants Pacifico Snacks the exclusive right to produce certain types of mango, pineapple and banana products within Colombia.

  • GlobeNewswire

    EnWave Signs Technology License and Joint Development Agreement with GEA Lyophil GmbH to Advance REV™ Technology for Pharmaceutical Applications

    EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave,” or the "Company”) today announced signing a technology license and joint development agreement (the “JDA”) with GEA Lyophil GmbH (“GEA Lyophil”), a global manufacturer and marketer of freeze-dry units for the pharmaceutical and biotech industries, to accelerate the potential commercialization of EnWave’s Radiant Energy Vacuum (“REV™”) technology in the pharmaceutical industry. The Company signed a collaboration and license option agreement with GEA Lyophil in July 2018 and the two parties have been working closely with EnWave’s existing pharmaceutical partner since that time to discuss and strategize the next steps of development towards prospective commercialization.

  • GlobeNewswire

    EnWave Signs Commercial Royalty-Bearing License with KL Ballantyne Pty Ltd and Receives Purchase Order for REV™ Machinery

    EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave,” or the "Company”) today announced signing a royalty-bearing commercial license (the “License”) with KL Ballantyne Pty Ltd (“Ballantyne”), a leading Australian dairy company. The License grants Ballantyne the exclusive right to produce dairy products in Australia using the Company’s patented Radiant Energy Vacuum (“REV™”) technology, excluding direct-to-consumer cheese snack products.

  • GlobeNewswire

    EnWave Receives Purchase Order for Large-Scale 100kW nutraREV® Processing Line from Fresh Business Peru

    EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") reports today that it has signed an Equipment Purchase Agreement (the “Agreement”) for the delivery of a 100kW nutraREV® processing line to Consulting FB Tech and Apps S.L. (“Fresh Business”) in Peru. The Agreement marks the scale-up of Fresh Business’ commercial operations in Peru, where it sources premium, highly nutritious fruit and vegetable products to be dried using EnWave’s Radiant Energy Vacuum (“REVTM”) technology for export to international markets.

  • Aurora Cannabis Provides Corporate Update and Confirms Cannabis 2.0 Roll Out
    CNW Group

    Aurora Cannabis Provides Corporate Update and Confirms Cannabis 2.0 Roll Out

    EDMONTON, Dec. 23, 2019 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE | TSX: ACB), the Canadian company defining the future of cannabis worldwide, today provided an update on the readiness of its operations with the introduction of new product formats, recent industry recognitions and updates to existing operations. As a global leader in cannabis revenues, cannabis production, research, innovation and international market development, the Company intends to provide regular updates to its stakeholders in an effort to demonstrate continued transparency and disclosure.

  • CNW Group

    Aurora Cannabis Announces Change to Executive Team: Cam Battley Steps Away From his Role as Chief Corporate Officer

    EDMONTON , Dec. 21, 2019 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE │ TSX: ACB), the Canadian company defining the future of cannabis worldwide, announces a change to the Executive Team. Cam Battley has stepped down as Chief Corporate Officer effective December 20, 2019 . Mr. Battley joined Aurora in 2016, serving a number of senior roles critical to the success of the company in its early years before being named Chief Corporate Officer in 2018.

  • GlobeNewswire

    EnWave Signs Commercial License Agreement with Responsible Foods in Iceland and Receives Purchase Order For REV™

    EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”) announced today that it has signed a royalty-bearing commercial license agreement (the “License”) with Responsible Foods ehf (“Responsible Foods”) to produce Radiant Energy Vacuum (“REV™”) dried snacks and ingredients using premium Icelandic raw materials.These REV™-dried applications will be sold in both domestic and international markets. Under the terms of the License, Responsible Foods purchased a 10kW commercial REV™ machine to initiate production in Iceland. The License grants Responsible Foods the exclusive right to process a variety of unique and healthy food products in Iceland including, but not limited to, dairy products, seafood, meat, microalgae and seaweed, and a variety of herbs, berries and mushrooms native to Iceland.

  • GlobeNewswire

    EnWave Announces Grant of Stock Options

    EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") announced today that it has granted an aggregate of 685,000 incentive stock options pursuant to the Company’s Stock Option Plan (the “Plan”) to one director and certain employees of the Company. The incentive stock options are exercisable at a price of $1.74 per share, the last closing price per share on the Company’s common shares on the TSX Venture Exchange (“TSXV”) on the date of the grant.

  • GlobeNewswire

    EnWave Signs Equipment Purchase Agreement and Royalty-Bearing License for Drying Cannabis in New Zealand with Helius Therapeutics Ltd.

    EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”) reports today that EnWave has signed an exclusive, royalty-bearing commercial license (the "License") with Helius Therapeutics Ltd. (“Helius”). Helius is New Zealand's largest licensed medical cannabis company with a strong focus on research and development. It is also the first cannabis company in the world to be certified as New Zealand Grown.

  • GlobeNewswire

    EnWave Announces Fourth Quarter and 2019 Annual Consolidated Financial Results 

    VANCOUVER, British Columbia, Dec. 11, 2019 -- EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") is pleased to report the Company’s consolidated financial.

  • GlobeNewswire

    EnWave to Report Fourth Quarter 2019 Financial Results on December 10, 2019 and Host Investor Conference Call

    VANCOUVER, British Columbia, Dec. 04, 2019 -- EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company"), a global leader in vacuum microwave dehydration technology,.

  • CNW Group

    Aurora Cannabis Achieves Highest Cannabis Corporate Boards Ranking in 2019 Globe & Mail Board Games Report

    EDMONTON, Dec. 2, 2019 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE │ TSX: ACB), the Canadian company defining the future of cannabis worldwide, is pleased to acknowledge the Company's ranking in the 2019 annual Report on Business ("ROB") review of Corporate Boards, known as Board Games. Published in its 18th year, the ROB Board Games considers dozens of governance criteria, extending beyond those required by formal regulations. Aurora achieved a score of 67 (out of a total score of 100), representing a significant increase over the prior year, a substantially higher ranking than others in its peer group of companies.

  • CNW Group

    Aurora Receives First Approval for Medicinal Cannabis Product in Ireland

    EDMONTON, Dec. 2, 2019 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE │ TSX: ACB), the Canadian company defining the future of cannabis worldwide, today announced that one of the Company's oil products has now been approved for use under Ireland's new Medical Cannabis Access Programme (MCAP). Aurora's High CBD Oil Drops received approval from the Irish authorities and have now been added to a regulatory schedule by the Irish Minister of Health enabling importation, prescribing and supply under the scheme and is to date, one of only two products to gain such authorization.

  • Aurora Cannabis Opens Experiential Flagship Store in North America's Largest Mall
    CNW Group

    Aurora Cannabis Opens Experiential Flagship Store in North America's Largest Mall

    EDMONTON , Nov. 27, 2019 /CNW/ - Aurora Cannabis Inc. ("Aurora") (NYSE | TSX: ACB), the Canadian company defining the future of cannabis worldwide, today announced the grand opening of its flagship retail store at 10:00 a.m. MT on November 27 th in the West Edmonton Mall, North America's largest mall. At approximately 11,000 square feet, Aurora has combined both a retail cannabis store and an immersive experiential space, encouraging visitors from around the world to explore unique products and participate in a rotating calendar of programming and events. Aurora's flagship store offers visitors a safe, age-gated retail experience in full compliance with all relevant federal and provincial regulations.

  • GlobeNewswire

    EnWave Signs Commercial Royalty-Bearing License and Equipment Lease Agreement with a Swiss Medical CBD Company

    EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave,” or the "Company”) today announced signing a royalty-bearing commercial license agreement (the “License”) and equipment lease agreement (the “Lease”) with a Medical Cannabidiol (“CBD”) Company based in Switzerland (the “Royalty Partner”). The License grants the Royalty Partner a non-exclusive right to process medicinal-grade hemp for cannabidiol CBD extraction in Switzerland using the Company’s patented Radiant Energy Vacuum (“REV™”) technology.

  • CNW Group

    Aurora Cannabis Announces Pricing of Early Amended Conversion Privilege for Convertible Debentures

    NYSE | TSX: ACB   EDMONTON , Nov. 25, 2019 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE │ TSX: ACB), the Canadian company defining the future of cannabis worldwide, ...

  • CNW Group

    View from the C-Suite: Glen Ibbott, Chief Financial Officer, Aurora Cannabis Inc., tells his company's story. Filmed on October 16, 2019

    View from the C-Suite: Glen Ibbott, Chief Financial Officer, Aurora Cannabis Inc., tells his company's story. Filmed on October 16, 2019

  • CNW Group

    Aurora Cannabis Strengthens Leadership Team Adding Chief Product Officer and Chief Integration Officer

    Appoints Dr. Shane Morris CPO and André Jérôme CIO TSX | NYSE: ACB   EDMONTON , Nov. 20, 2019 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE │ TSX: ACB), the Canadian ...